Table 3.
CT2 | CT6 | CT10 | CT14 | CT21 | |
---|---|---|---|---|---|
One-way ANOVA | |||||
Ringer’s | 0.814 | 0.578 | 0.620 | 0.120 | 0.011 |
11 | 11 | 11 | 7 | 8 | |
Anta | 0.000 | 0.000 | 0.000 | 0.545 | 0.111 |
11 | 10 | 13 | 6 | 8 | |
Two-way ANOVA | |||||
Drug | 0.661 | 0.286 | 0.937 | 0.725 | 0.660 |
Sampling | 0.004 | 0.001 | 0.103 | 0.070 | 0.009 |
D × S | 0.042 | 0.000 | 0.005 | 0.831 | 0.203 |
One-way ANOVA shows the p values for the Sampling effects of either Ringer’s or V1 antagonist (Anta) application on plasma ACTH values at the different CT. Two-way ANOVA indicates the significance of differences between absolute plasma ACTH values on Ringer’s and VP antagonist administration (Fig. 4). Number of animals is indicated in italics.